Hana Pharm Co Ltd (293480) — Strategic Asset Allocation Index
Hana Pharm Co Ltd (293480) has a Strategic Asset Allocation Index of 58.9% as of December 2017. Strategic assets (PP&E of ₩46.65 Billion plus long-term investments of ₩1.23 Billion) total ₩47.89 Billion, measured against net assets of ₩81.30 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Hana Pharm Co Ltd to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Hana Pharm Co Ltd Strategic Asset Allocation Index (2016–2017)
This chart shows how Hana Pharm Co Ltd's Strategic Asset Allocation Index has evolved across 2 annual periods from 2016 to 2017. As of December 2017, the index stands at 58.9%, representing strategic assets of ₩47.89 Billion against net assets of ₩81.30 Billion KRW. For live market cap and overall valuation, see Hana Pharm Co Ltd market cap and net worth.
Annual Strategic Asset Allocation Index for Hana Pharm Co Ltd (2016–2017)
The table below presents the year-by-year Strategic Asset Allocation Index for Hana Pharm Co Ltd from 2016 to 2017, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 293480 net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2017 | 58.9% | ₩47.89 Billion | ₩46.65 Billion | ₩1.23 Billion | ₩81.30 Billion | ▼ -32.7 pp |
| 2016 | 91.6% | ₩50.82 Billion | ₩49.66 Billion | ₩1.15 Billion | ₩55.48 Billion | — |